Plain-English translation of NCT04057209 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing two well-established treatments for early-stage vocal cord cancer: transoral CO2-laser surgery and single vocal cord radiation therapy. Both treatments work equally well at controlling the cancer, but doctors don't yet know which one preserves your voice quality better in the long term. This trial will randomly assign you to receive one treatment or the other, then carefully measure how your voice changes over time.
Although both laser surgery and radiation therapy are proven to treat early vocal cord cancer effectively, no large, properly designed study has directly compared them—especially when it comes to voice quality, which is critical to patients' quality of life. This trial exists to give doctors and patients clear evidence about which treatment is more likely to preserve a healthy voice.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either laser microsurgery (performed in one day with a short hospital stay) or radiation therapy (daily outpatient visits over several weeks). Before and after treatment, your voice quality will be assessed using standardized voice tests and questionnaires. You will have follow-up visits to monitor your voice and ensure the cancer does not return, with detailed measurements of how your voice changes over time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France
India
Switzerland